Cero Therapeutics Holdings, Inc. (CERO): Operating Income

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Operating Income is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

-$7.68M

Year ended 2023-12-31

2022-12-31 Operating Income (USD) 2023-12-31

Period ended	Operating Income	Change YoY	Source filing
2023-12-31	-$7.68M	n/m	2025-04-15, From 2023-01-01
2022-12-31	-$2.91M	n/a	2024-04-02, From 2022-01-01